首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis.
【24h】

Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis.

机译:成功地在耐万古霉素的肠球菌性腹膜炎的CAPD患者中成功使用静脉注射利奈唑胺。

获取原文
获取原文并翻译 | 示例
       

摘要

In CAPD peritonitis caused by vancomycin-resistant enterococci (VRE), treatment by antibiotics such as quinupristin-daLfopristin (Synerdd: DSM Pharmaceuticals, Greenville, NC, U.S.A.), Linezolid (Zyvox: Pfizer, New York, NY, U.S.A.), ordaptomycin has been attempted (1). Treatment without removal of the peritoneal catheter has not been reported exceptfor 2 cases recently treated with intraperitonealdaptomycin (2), and standards for removal of the peritoneal dialysis catheter have not been established. We describe a case of peritonitis caused by VRE that developed in a CAPD patient and that was treated successfully with intravenous linezolid while maintaining a peritoneal dialysis catheter.
机译:在由耐万古霉素的肠球菌(VRE)引起的CAPD腹膜炎中,使用奎奴普丁-达氟普汀(Synerdd:DSM Pharmaceuticals,Greenville,NC,USA),Linezolid(Zyvox:Pfizer,New York,NY,USA)或奥托霉素来治疗抗生素被尝试(1)。除近期有2例使用腹膜内醛缩霉素治疗的病例外,尚未报道未切除腹膜导管的治疗方法(2),并且尚未建立切除腹膜透析导管的标准。我们描述了在CAPD患者中发生的由VRE引起的腹膜炎病例,在维持腹膜透析导管的同时,已成功用静脉注射利奈唑胺治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号